Gene Query: SLCO2B1

Dataset Description Geneva Score
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 50.44
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 47.92
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 44.08
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 40.46
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 40.46
Effects of rFVIIIFc on human macrophages 39.43
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 38.87
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 38.87
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 37.37
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 34.71
RNA-sequencing of human tendon after injury 34.24
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 30.07
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 29.75
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 29.15
Generation and functional characterization of MDSC-like cells 28.53
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 27.19
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 27.16
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 26.76
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 26.62
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 26.01
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 26.01
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 26.0
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 25.26
Transcriptome wide analysis of classically and alternatively activated macrophages 24.64
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 24.61
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 24.45
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 24.45
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 24.11
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 23.33
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 23.33
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 22.18
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 22.18
Region-specific Innate Antiviral Responses of the Human Epididymis 21.88
NAPRT activation of macrophages 20.81
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 20.29
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 19.59
Nonpregnant and term pregnant human myometrial tissues 19.59
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 19.58
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 19.55
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 19.32
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 18.74
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 18.27
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 18.19
Efficient derivation of microglia-like cells from human pluripotent stem cells 17.93
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 17.75
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 17.75
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 17.74
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 17.74
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 17.69
Gene expression analysis of human liver progenitor-like cells in culture 17.48
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 17.1
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 17.1
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 16.98
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 16.34
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 16.27
Microglia innatly develop within cerebral organoids 16.08
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 15.45
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 15.23
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 14.99
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 14.95
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 14.8
Transcriptome analysis of virus infected tissues 14.73
RNA seq analysis of human Fetal and adult derived Enterospheres 14.55
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 14.53
RNA-seq of stable and unstable section of human atherosclerotic plaques 14.5
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 14.43
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 14.42
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 14.31
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 14.22
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 14.06
Postnatal lipids drive hepatocyte maturation 13.7
Trascriptome of thyroid cancer-induced macrophages 13.7
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 13.62
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 13.52
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 13.52
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 13.25
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 13.08
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 12.46
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 12.46
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 12.45
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 12.45
Total RNA sequencing of WT intestinal orgaonids. 12.34
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 12.2
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 12.05
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 12.04
Reprogrammed myeloid cell transcriptomes in NSCLC 12.03
Total RNA sequencing of APC mutant and wt colonic organoids 11.77
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 11.75
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 11.75
Gene expression profiling of human MSC-educated macrophages vs. classical macrophages from bone marrow and blood 11.61
Gene expression patterns define the hepatocyte-like cells derived by different strategies 11.52
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 11.52
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 11.5
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 11.27
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 11.26
Transcriptional profiling of LS1034 cells treated with tepoxalin 11.11
Hepatocyte maturation 10.72
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 10.57
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 10.4
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 10.36
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 10.32
MEIS1 regulates hematopoiesis in hPSCs 10.1
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 10.03
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 10.03
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 10.0
RNA-seq of CD33 KO and control HSPCs 9.97
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.93
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.93
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 9.87
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 9.77
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 9.6
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 9.53
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 9.53
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 9.52
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 9.43
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 9.36
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 9.31
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 9.03
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 9.0
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 8.92
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 8.75
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 8.68
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 8.66
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 8.65
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 8.52
Macrophage Ad5f35 PhenoMap 8.46
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 8.33
Differentially expressed genes post knock down of lincDUSP26 8.14
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 8.14
Dermal endothelial cells of type 2 diabetic patients 8.11
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 8.11
Irf9 function in immunity in mouse 8.11
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 8.08
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 8.05
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 8.04
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.87
ZIKV infection of monocytes activates inflammasome pathways 7.86
HNF1 regulates critical functions of the human epididymis epithelium. 7.83
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 7.83
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 7.81
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 7.78
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 7.72
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 7.7
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.58
Primary human trophoblast from term placenta 7.57
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 7.5
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 7.5
Transciptomic profiling of human fetal lung samples 7.46
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 7.36
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.26
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 7.23
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 7.21
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 7.15
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 7.14
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 7.14
Evolution of a transcriptional regulator from a transmembrane nucleoporin 7.02
RNA-seq in HepG2 and IMR90 cells 7.02
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 6.91
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 6.91
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 6.91
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 6.85
RNA-seq in endometrial stromal tumors 6.79
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 6.77
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 6.73
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 6.73
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 6.7
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 6.66
Gene expression profiling in metabolically heterogeneous human lung tumors 6.6
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 6.59
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 6.55
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 6.5
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 6.43
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 6.39
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 6.37
Identification of Sin3B regulated genes during quiescence 6.3
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 6.3
Universal alternative splicing of noncoding exons 6.24
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 6.22
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 6.16
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 6.14
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 6.14
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 6.13
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.05
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.01
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 6.0
Gene expression analysis of immortalized human liver progenitor-like cells in culture 5.97
Non-coding regions are the main source of tumor-specific antigens 5.8
Non-coding regions are the main source of tumor-specific antigens [human] 5.8
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 5.79
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 5.73
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 5.68
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 5.68
Functional Screening in Human Cardiac Organoids Reveals a Metabolic Mechanism for Cardiomyocyte Maturation 5.59
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 5.54
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 5.48
An acquired vulnerability of drug resistant melanoma with therapeutic potential 5.48
Crizotinib v. DMSO in SW480 cells 5.39
Derivation and differentiation of haploid human embryonic stem cells [RNA-Seq 1] 5.38
Gene expression profiling of papillary thyroid cancer from central and invasive regions 5.37
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 5.36
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 5.3
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 5.16
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 5.13
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.06
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 5.04
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 5.02
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 4.97
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 4.96
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 4.86
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 4.75
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 4.75
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 4.64
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 4.64
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 4.6
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 4.6
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 4.56
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 4.54
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 4.54
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 4.52
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 4.5
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 4.42
The DNA methylation landscape of human melanoma 4.42
The DNA methylation landscape of human melanoma [RNA-Seq] 4.42
FOXD3 is a novel tumor suppressor in lung cancer 4.41
U2AF1 mutations alter splice site recognition in hematological malignancies 4.34
RNA Sequencing of three pairs of gastric cancer 4.34
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 4.33
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 4.26
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 4.26
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 4.24
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 4.23
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 4.23
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 4.22
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 4.19
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 4.18
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 4.18
MHC Transcriptomic landscape at haplotype-specific resolution 4.16
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 4.02
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 3.97
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 3.91
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.9
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 3.89
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 3.89
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.88
circRNA-sequencing 3.81
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 3.79
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 3.74
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 3.73
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 3.69
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 3.68
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 3.68
Direct Isolation and Characterization of Human Nephron Progenitors. 3.64
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 3.63
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 3.63
A practical evaluation of alignment algorithms for RNA variant calling analysis 3.57
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 3.53
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 3.53
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 3.53
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 3.51
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 3.51
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 3.51
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 3.51
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 3.51
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 3.47
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 3.43
Aortic Valve Tissue: Stenosis vs. Sclerosis 3.43
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 3.38
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 3.38
Comparison of microRNA Profiling Platforms 3.36
Comparison of microRNA Profiling Platforms (HTS) 3.36
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 3.35
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 3.35
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 3.35
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 3.32
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 3.31
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 3.23
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.21
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 3.19
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 3.14
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 3.13
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.13
Noncoding regions are the main source of targetable tumor-specific antigens 3.11
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 3.06
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.06
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 3.01
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.98
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 2.98
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 2.93
RNA-seq melanoma 2.89
Gene expression profile difference among renal location in a stone former 2.88
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 2.87
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.85
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.85
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.82
Patient-derived xenograft platform for metastatic melanoma 2.82
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.79
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 2.77
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.76
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 2.76
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 2.69
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 2.68
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.66
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.65
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 2.64
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.63
The age and genomic integrity of neurons after cortical stroke in humans 2.63
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 2.63
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.62
circRNA profile in hypopharyngeal cancer 2.6
RNA-sequencing 2.59
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 2.59
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 2.59
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.58
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 2.57
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 2.57
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 2.57
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 2.55
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 2.52
Global analyses of the effect of different cellular contexts on microRNA targeting 2.52
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.5
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.49
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.49
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 2.47
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.46
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 2.44
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 2.44
Single cell transcriptome of peritoneal cells 2.43
oxLDL exposed trained monocytes 2.4
Transcriptomes of oxLDL exposed trained monocytes 2.4
The expression profiles of GBC liver metastasis 2.35
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 2.35
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 2.3
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 2.27
Reducing the structure bias of RNA-Seq reveals a large number of non-annotated non-coding RNA 2.26
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 2.24
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 2.23
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 2.22
Fibroblasts in cholesteatoma activate osteoclasts. 2.2
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 2.18
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.18
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 2.16
Derivation and differentiation of haploid human embryonic stem cells 2.16
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 2.14
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 2.14
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 2.11
Measure transcript integrity using RNA-seq data 2.11
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 2.08
Repurposing of promoters and enhancers during mammalian evolution 2.06
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 2.06
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 2.03
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 2.03
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.02
MARCKS and lnc-MARCKS act as inflammation regulators 1.99
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 1.94
Hepatic transcriptome of pediatric hepatoblastoma. 1.85
Single-cell analysis of adult human ovary using 10X genomics 1.84
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 1.82
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 1.81
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.78
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 1.78
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 1.76
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 1.73
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 1.73
Molecular analysis of renal cell carcinoma with unclassfied histology 1.72
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 1.72
Transcriptomes in healthy and CHB fetal hearts 1.7
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.64
RNA-seq analysis of the human fetal kidney. 1.63
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 1.63
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 1.63
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.63
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 1.57
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 1.56
Transcriptome of Stabilin-1 siRNA transfected human monocytes 1.54
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.54
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.54
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.53
Identification of expressed and conserved human non-coding RNAs 1.52
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 1.52
The gene expression profiles of gallbladder cancer 1.51
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.51
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 1.51
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 1.47
MAIT cell RNA sequencing 1.46
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.46
Hepatosplenic T cell lymphoma 1.46
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.45
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.45
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 1.43
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 1.4
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 1.4
RNA expression profiles comparing primary and omental ovarian carcinoma samples 1.4
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.4
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.4
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 1.4
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 1.39
Persistence of stem cell metabolism in cancers as a failure of differentiation 1.35
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.33
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.33
RNA-Seq of the corpus callosum from 12 individuals 1.33
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 1.31
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.31
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 1.3
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 1.3
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 1.3
Epigenome regulation during epidermal lineage commitment 1.3
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.26
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 1.21
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.18
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 1.17
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 1.16
Global epigenomic reconfiguration during mammalian brain development 1.12
Zika virus infection reprograms global transcription of host cells to allow sustained infection 1.1
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 1.09
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 1.07
Gene profiling of human adult and pediatric liver cancer cells 1.07
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 1.04
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 1.04
Transcriptome sequencing of K-562 cells 1.01
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.98
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.96
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.96
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 0.94
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.91
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.91
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.9
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 0.9
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 0.9
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.9
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.88
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.85
Gene expression of collecting duct carcinoma of the kidney 0.85
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 0.83
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.82
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 0.81
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 0.8
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 0.8
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.76
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.75
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.73
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.7
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.7
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 0.69
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.69
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.66
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 0.64
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.63
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.63
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 0.63
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.62
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.62
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.61
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.58
Transcriptomes of human monocytes after ex vivo exposure to uric acid 0.52
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 0.51
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 0.51
Transcriptome analysis reveals differential splicing events in IPF lung tissue 0.51
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.5
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.48
RNA-Seq and expression data from human adipose tissue 0.48
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 0.47
The transcriptome of Kawasaki Disease arteritis 0.47
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.44
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 0.44
Gene expression analysis of human hepatocellular cancers 0.43
Human ovarian granulosa cell transcriptome 0.43
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.41
RNAseq in Alzheimer's Disease patients 0.39
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 0.39
Deep RNA sequencing of the human placental transcriptome 0.36
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.36
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.36
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 0.35
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 0.35
Human optic chiasm from healthy controls and multiple sclerosis patients 0.33
Multiple sclerosis and EAE 0.33
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.32
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.32
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.3
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 0.28
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 0.26
Transcriptomic profiling of human peripheral blood-derived mast cells 0.26
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.26
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.25
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.25
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 0.24
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.2
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 0.2
RNAseq analysis of ruxolitinib treated breast cancers 0.2
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 0.16
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 0.15
A single cell reference map for human blood and tissue T cell activation 0.15
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 0.15
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.14
RNA-Sequencing of HepG2 cells treated with TGFBeta 0.09
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.09
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.07
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.05
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.05
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation